Company / Shares Outstanding
SAB Biotherapeutics, Inc. Shares Outstanding History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
9.3M
FY2025
5-year range
5.0M / 26.0M
FY2021-FY2025
Trend
+0.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from 5040236.00 to 9288868.00 over the past 2 years.
Based on SEC 10-K filings.
9288868.00 in FY2025 with a 3-year CAGR of -29.0%.
Increased from 5040236.00 to 9288868.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -29.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, shares outstanding increased 0.7% year-over-year.
- Peak shares outstanding was recorded in FY2022.
- Lowest shares outstanding in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.31 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 9.3M | +0.7% |
| FY2024 | 9.2M | +83.0% |
| FY2023 | 5.0M | -80.6% |
| FY2022 | 26.0M | +0.0% |
| FY2021 | 26.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026